Tony Day is a biotechnology executive and advisor with more than 30 years of experience building companies and commercializing breakthrough technologies at the intersection of biology, chemistry, and consumer products. He currently serves as Venture Partner at Genoa Ventures and is Co-founder and partner at Hawkwood Biotech, where he advises emerging and established companies on scale-up, strategy, partnerships, and market entry across industrial biotech, food tech, and sustainable ingredients.He started his career in R&D at the industrial enzyme company Genencor (now part of IFF) and following that an early employee and senior executive at Solazyme, where he served as Head of R&D and later VP of Commercialization. His work spans enzymology, molecular genetics, sustainability, regulatory strategy, and the translation of laboratory innovation into scalable manufacturing platforms.At this panel, Tony brings a rare perspective on how biosurfactants can move from promising molecules to scaled, market-shaping products.